NCT02489071

Brief Summary

This study evaluates the feasibility and utility of two behavioural programs designed to reduce cognitive impairments secondary to brain tumors and/or their treatment. One-third of participants will complete training in either program, with the remaining third a wait-list control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2015

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

September 27, 2018

Status Verified

September 1, 2018

Enrollment Period

4 years

First QC Date

June 16, 2015

Last Update Submit

September 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in cognitive composite score

    Summation of standardized change scores on neuropsychological tests

    baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)

Secondary Outcomes (3)

  • Change in functional composite score

    baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)

  • Change in quality of life composite score

    baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)

  • Change in caregiver quality of life composite score

    baseline, 2 months (0-2 weeks post-training), 6 months (4 months post-training)

Study Arms (3)

Brain Training

EXPERIMENTAL

8-session cognitive training program

Behavioral: Brain Training Program

Brain Health

EXPERIMENTAL

8-session cognitive education program

Behavioral: Brain Health Program

Control

NO INTERVENTION

Wait-list control group

Interventions

Brain Training
Brain Health

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18 or older
  • fluent in English
  • able to provide informed consent to all procedures
  • diagnosis of a brain tumor
  • indication of lasting post-treatment cognitive deficits (e.g., from clinical presentation, prior neuropsychological assessment, and/or self-report)
  • sufficient motor and sensory functioning to complete study activities
  • availability to complete all study activities
  • for patients treated with cranial radiation, at least 3 months post-radiation

You may not qualify if:

  • (1) comorbid neurological or psychiatric disorder or other medical condition suspected to influence cognition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Margaret Cancer Centre

Toronto, Ontario, M5S1W8, Canada

Location

Related Publications (1)

  • Richard NM, Bernstein LJ, Mason WP, Laperriere N, Maurice C, Millar BA, Shultz DB, Berlin A, Edelstein K. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. J Neurooncol. 2019 May;142(3):565-575. doi: 10.1007/s11060-019-03130-1. Epub 2019 Mar 7.

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Kim Edelstein, PhD

    Princess Margaret Cancer Centre, University Health Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2015

First Posted

July 2, 2015

Study Start

August 1, 2014

Primary Completion

August 1, 2018

Study Completion

August 1, 2018

Last Updated

September 27, 2018

Record last verified: 2018-09

Locations